@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ns1: <http://purl.org/spar/pro/> .
@prefix ns2: <http://purl.org/spar/datacite/> .
@prefix ns3: <http://prismstandard.org/namespaces/basic/2.0/> .
@prefix ns4: <http://purl.org/vocab/frbr/core#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<> dcterms:license <https://creativecommons.org/publicdomain/zero/1.0/legalcode> .

<https://w3id.org/oc/meta/br/06403958429> a <http://purl.org/spar/fabio/Expression>,
        <http://purl.org/spar/fabio/JournalArticle> ;
    rdfs:label "br 06403958429" ;
    ns3:publicationDate "2022-11-25"^^xsd:date ;
    dcterms:title "A Randomized, Controlled Trial Of ZYN002 Cannabidiol Transdermal Gel In Children And Adolescents With Fragile X Syndrome (CONNECT-FX)" ;
    ns2:hasIdentifier <https://w3id.org/oc/meta/id/06403565941>,
        <https://w3id.org/oc/meta/id/06405983948> ;
    ns1:isDocumentContextFor <https://w3id.org/oc/meta/ar/064015906732>,
        <https://w3id.org/oc/meta/ar/064015906733>,
        <https://w3id.org/oc/meta/ar/064015906734>,
        <https://w3id.org/oc/meta/ar/064015906735>,
        <https://w3id.org/oc/meta/ar/064015906736>,
        <https://w3id.org/oc/meta/ar/064015906737>,
        <https://w3id.org/oc/meta/ar/064015906738>,
        <https://w3id.org/oc/meta/ar/064015906739>,
        <https://w3id.org/oc/meta/ar/064015906740>,
        <https://w3id.org/oc/meta/ar/064015906741>,
        <https://w3id.org/oc/meta/ar/064015906742>,
        <https://w3id.org/oc/meta/ar/064015906743>,
        <https://w3id.org/oc/meta/ar/064015906744>,
        <https://w3id.org/oc/meta/ar/064015906745>,
        <https://w3id.org/oc/meta/ar/064015906746> ;
    ns4:partOf <https://w3id.org/oc/meta/br/06403959192> .

